GUÍAS Y PROCEDIMIENTOS:

Guidelines for the clinical use of cardiac radionuclide imaging  Executive Summary. American College of Cardiology / American Heart Association task force on practice guidelines. 2003.

Updated imaging guidelines for nuclear cardiology procedures. 2001.

Procedure guidelines for radionuclide myocardial perfusion imaging. British Cardiac Society, British Nuclear Cardiology Society, British Nuclear Medicine Society.

ASNC consensus statement. Reporting of radionuclide myocardial perfusion imaging studies. American Society of Nuclear Cardiology. 2003.

Standarized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Cardiol 2002; 9: 240-5.

PET myocardial glucose metabolism and perfusion imaging. American Society of Nuclear Cardiology Practice Guidelines.

REFERENCIAS BÁSICAS:

Fundamentals of endothelial function for the clinical cardiologist.
Verma S; Anderson T. Circulation 2002; 105: 546-549.

Myocardial perfusion and coronary microcirculation: from pathophysiology to clinical application. LAbbate A; Sambuceti G; Neglia D. J Nucl Cardiol 2002; 9: 328-37.

An overview of radiotracers in nuclear cardiology. Acampa W; Di Benedetto C; Cuocolo A. J Nucl Cardiol 2000; 7: 701-707.

Use of myocardial perfusion imaging to assess viability. Travin M. J Nucl Cardiol 2000; 7: 72-80.

éóTcnicas de medicina nuclear en la identificacin de miocardio viable. Jurado J; Cano J. Monocardio 2002; 4: 25-42.

Heterogeneity of myocardial blood flow and metabolism: review of physiologic principles and implications for radionuclide imaging of the heart. Gewirtz H; Tawakol A; Bacharach S. J Nucl Cardiol 2002; 9: 534-41.

Role of nuclear cardiac imaging in myocardial infarction: postinfarction risk stratification. Mahmarian J; Dwivedi G; Lahiri T. J Nucl Cardiol 2004; 11: 186-209.

The historical and conceptual evolution of radionuclide assessment of myocardial viability. Udelson J; Bonow R; Dilsizian V. J Nucl Cardiol 2004; 11: 318-34.

Advances in nuclear cardiology: preoperative risk stratification. Brown K. J Nucl Cardiol 2004; 11: 335-48.

Antianginal medications and diagnostic accuracy of myocardial perfusion imaging. Kumar N; Lahiri A. J Nucl Cardiol 2003; 10: 433-35.

 

TOMOGRAFÍA COMPUTARIZADA DE FOTÓN ÚNICO (SPECT)

GEMS Millenium MG - CDD Las Mercedes

Quantification of SPECT myocardial perfusion imaging. Acampa W; He W; Di Nuzzo C; Cuocolo A. J Nucl Cardiol 2002; 9: 338-42.

Myocardial sestamibi uptake in healthy subjects is related to age, gender and habitus. Bouvier F; Bevegard S; Nejat M; Jensen-Urstad M. Clinical Physiol 1999; 19: 76-83.

SPECT PRONÓSTICO:

Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms. An evaluation of incremental prognostic value and cost-effectiveness. Hachamovitch R; Berman D; Kiat H; Cohen I; Friedman J; Shaw L. Circulation 2002; 105: 823-829.

Long term prognosis after a normal exercise stress Tc-99m sestamibi SPECT study. Elhendy A; Schinkel A; Bax J; van Domburg R; Poldermans D. J Nucl Cardiol 2003; 10: 261-6.

Risk stratification of the normal perfusion scan: does normal stress perfusion always mean very low risk? Dahlberg S; Leppo J. J Nucl Cardiol 2003; 10: 87-91.

Comparison of the cost-efectiveness of stress myocardial SPECT and stress echocardiography in suspected coronary artery disease considering the prognostic value of false-negative results. Soo L; Jin M; Jeong G; Chung JK; Chul M. J Nucl Cardiol 2002; 9: 515-22.

Effect of endothelial dysfunction on regional perfusion in myocardial territories supplied by normal and diseased vessels in patients with coronary artery disease. Masoli O; Prez N; Sabat D; Jaln J; Meretta A; Cragnolino D; Sarmiento R; DiCarli M. J Nucl Cardiol 2000; 7: 199-204.

Prognostic value of gated myocardial perfusion SPECT. Shaw L; Iskandrian A. J Nucl Cardiol 2004; 11: 171-85.

Prognostic significance of ischemic electocardiographic changes during vasodilator strees testing in patients with normal SPECT images. Klodas E; Miller T; Christian T; Hodge D; Gibbons R. J Nucl Cardiol 2003; 10: 4-8.

The prognostic value of ECG-gated SPECT imaging in patients undergoing stress Rc-99m sestamibi myocardial perfusion imaging. Travin M; Heller G; Johnson L; Katten D; Ahlberg A; Isasi C; Kaplan R; Taub C; Demus D. J Nucl Cardiol 2004; 11: 252-262.

Incidence and predictors of heart failure during long-term follow-up after stress Tc-99m sestamibi tomography in patients with suspected coronary artery disease. Elhendy A; Schinkel A; van Domburg R; Bax J; Poldermans D. J Nucl Cardiol 2004; 11: 527-33.

Prediction of death and nonfatal myocardial infarction in high-risk patients: a comparison between the Duke treadmill score, peak exercise radionuclide angiography, and SPECT perfusion imaging. Liao L; Smith W; Tuttle R; Shaw L; Coleman R; Borges-Neto S. J Nucl Med 2005; 46:5-11.

Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. Sharir T; Germano G; Kang X; Lewin H; Miranda R; Cohen I; Agafitei R; Friedman J; Berman D. J Nucl Med 2001: 42: 831-837.

Risk stratification of patients after myocardial revascularization by stress Tc-99m tetrofosmin myocardial perfusion tomography. Elhendy A; Schinkel A; van Domburg R; Bax J; Valkema R; Poldermans D. J Nucl Cardiol 2003; 10: 615-22.

Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications? Romero-Farina R; Candell-Riera J; Galve E; Armadans L; ramos F; Castell J; Aguad S; Nogales J; Soler-Soler J. J Nucl Cardiol 2004; 11: 578-86.

Comparison of Tl-201 with Tc-99m-labelled myocardial perfusion agents: technical, physiologic, and clinical studies. Kailasnath P; Sinusas A. J Nucl Cardiol 2001; 8:482-98.

Anatomy of a meta-analysis: a critical review of exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. Kymes S; Bruns D; Shaw L; Gillespie K; Fletcher J. J Nucl Cardiol 2000; 7: 599-615.

Estimation of coronary flow reserve: can SPECT compete with other modalities? Gullberg G; Di Bella E; Sinusas A. J Nucl Cardiol 2001; 8: 620-5.

SPECT y CALCIO CORONARIO:

Compementary roles of coronary calcium scanning and myocardial perfusion SPECT. Berman D. J Nucl Cardiol 2004; 11: 379-81.

ESTRÉS FARMACOLÓGICO:

Clinical considerations in cardiac stress testing. Latus K; Underwood R. J Nucl Cardiol 2001; 8: 410-4.

Prognostic value of normal exercise and adenosine 99mTc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. Shaw L; Hendel R; Borges-Neto S; Lauer M; Alazraki N; Burnette J; Krawczynska E; Cerqueira M; Maddahi J. J Nucl Med 2003; 44: 134-139.

Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis. Navare S; Mather J; Shaw L;Fowler M; Heller G. J Nucl Cardiol 2004; 11: 551-61.

Prognostic significance of ischemic electrocardiographic changes during adenosine infusion in patients with normal myocardial perfusion imaging. Abbott B; Afshar M; Berger A; Wackers F. J Nucl Cardiol 2003; 10: 9-16.

TOMOGRAFÍA DE EMISIÓN DE POSITRONES (PET) Y
FUSION DE LA TOMOGRAFÍA COMPUTARIZADA (CT) y PET (PET/CT)

PET/CT GEMS Discovery LS - CDD Las Mercedes

FISIOLOGÍA:

Cellular and molecular regulation of cardiac glucose transport. Young L; Coven D; Russell R. J Nucl Cardiol 2000; 7: 267-76.

Factors influencing predictive value of FDG imaging for evaluating myocardial viability. Maddahi J. J Nucl Cardiol 2004; 11: 524-6.

ARTEFACTOS EN EL PET CARDÍACO:

Common artifacts in PET myocardial perfusion images due to attenuation-emission misregistration: clinical significance, causes, and solutions. Loghin C; Sdringola S; Gould L. J Nucl Med 2004; 45: 1029-1039.

PET y PET/CT CON AMONIO:

Quantitative evaluation of myocardial blood flow and ejection fraction with a single dose of 13NH3 and gated PET. Okazawa H; Takahashi M; Hata T; Sugimoto K; Kishibe Y; Tsuji T. J Nucl Med 2002; 43: 999-1005.

CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner. Koepfli P; Hany T; Wyss C; Namdar M; Burger C; Konstantinidis A; Berthold T; von Schulthess G; Kaufmann P. J Nucl Med 2004; 45: 537-542.

Myocardial blood flow measurement by PET: technical aspects and clinical applications. Kaufmann P; Camici P.

Integrated PET/CT for the assessment of coronary artery disease: a feasibility study. Namdar M; hany T; Koepfli P; Siegrist P; burger C; Wyss C; Luscher T; von Schulthess G; Kaufmann P. J Nucl med 2005; 46: 930-935.

ESTUDIOS CLINICOS PET CARDÍACO:

Bicycle exercise stress in PET for assessment of coronary flow reserve: repeatability and comparison with adenosine test. Wyss C; Koepfli P; Mikolajczyk K; Burger C; von Schulthess G; Kaufmann P. J Nucl Med 2003; 44: 146-154.

Model-based analysis of electrocardiography-gated cardiac 18F-FDG PET images to assess left ventricular geometry and contractile function. Khorsand A; Graf S; Frank H; Kletter K; Sochor H; Mauer G; Schuster E; Globits S; Dudczak R; Porenta G. J Nucl Med 2003; 44: 1741-1746.

Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability. Ghesani M; DePuey G; Rozanski A. Echocardiography 2005; 22: 165-177.

F-18 fluorodeoxyglucose imaging in myocardial ischemia: beyond myocardial viability. Arrighi J. J Nucl Cardiol 2001; 8: 417-20.

Myocardial glucose utilization and optimization of 18F-FDG PET imaging in patients with non-insulin dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. Vitale G; deKemp R; Ruddy T; Williams K; Beanlands R. J Nucl Med 2001; 42: 1730-1736.

PET-measured response of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography. Schindler T; Nitzsche E; Olschewski M; Brink I; Mix M; Prior J; Facta A; Inubushi M; Just H; Schelbert H. J Nucl Med 2004; 45: 419-428.

PET for evaluation of differential myocardial perfusion dynamics after VEGF gene therapy and laser therapy in end-stage coronary artery disease. Tio R; Tan E; Jessurum G; Veeger N; Jager P; Slart R; de Jong R; Pruim J; Hospers G; Willemsen A; de Jongste M; van Boven A; van Veldhuisen D; Zijlstra F. J Nucl med 2004; 45: 1437-1443.

Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial 99mTc-MIBI SPECT and 18F-FDG PET. Zhang X; Liu X; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W. J Nucl Med 2001; 42: 1166-1173.

íIncremental prognostic value of left ventricular function by myocardial ECG-gated FDG PET imaging in patients with ischemic cardiomyopathy. Santana C; Shaw L; Garca E; Soler-Peter M; Candell-Riera J; Grossman G; Krawczynska E; Faber T; Ribera A; Vaccarino V; Halkar R; Di Carli M. J Nucl Cardiol 2004; 11: 542-50.

Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension. Kluge R; Barthel H; Pankau H; Seese A; Schauer J; Wirtz H; Seyfarth HS; Steinbach J; Sabri O; Winkler J. J Nucl med 2005; 46: 25-31.

OTRAS APLICACIONES:

Imaging atherosclerotic plaque inflammation with 18F-fluorodeoxyglucose positron emission tomography. Rudd J; Warburton E; Fryer T; Jones H; Clark J; Antoun N; Johnstrom P; Davenport A; Kirkpatrick P; Arch B; Pickard J; Weissberg P.

 

[Principal] [Sobre Nosotros] [Artículos] [Correo Interno] [Visualizador de Imágenes]

2005® Centro Diagnóstico Docente Las Mercedes
Todos Los Derechos Reservados
Realizado por
Luis Humberto Felice